Quantitative analysis for Apyx Medical Corporation (APYX) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (68.0) (grade B). 30 signals analyzed (24 differentiated alt-data).
APYX stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $3.76 | $3.44 | $3.46 |
| 2026-05-11 | $4.14 | $3.79 | $3.92 |
| 2026-05-21 | $4.25 | $3.74 | $4.25 |
| 2026-06-03 | $3.92 | $3.75 | $3.79 |
| 2026-06-15 | $4.89 | $4.55 | $4.60 |
| 2026-06-26 | $4.52 | $4.13 | $4.50 |
| 2026-07-09 | $4.49 | $4.21 | $4.46 |
| 2026-07-21 | $4.35 | $4.10 | $4.12 |
| 2026-07-31 | $4.13 | $3.97 | $4.10 |
| 2026-08-12 | $3.09 | $2.89 | $2.99 |
| 2026-08-24 | $3.19 | $2.98 | $3.08 |
| 2026-09-03 | $3.08 | $2.96 | $3.06 |
How Apyx Medical Corporation stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| PLYX | Polaryx Therapeutics, Inc. Common Stock | $160M | — |
| SPRO | Spero Therapeutics, Inc. | $152M | — |
| IMDX | Insight Molecular Diagnostics Inc. | $166M | — |
| ASRT | Assertio Holdings, Inc. | $151M | — |
View all Health Care stocks by valuation and signals →
Apyx Medical Corporation (APYX) scores Buy (68.0), and the composite conceals a 88-point disagreement between its dimensions. It is strongest on competitive moat at 94 and technicals at 60, and weakest on analyst consensus at 6. A stock can carry competitive moat that high while analyst consensus sits at 6; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 94 |
| technicals | 60 |
| ML forecast | 55 |
| analyst consensus | 6 |
StoQuant analyzes 30 signals (24 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Apyx Medical Corporation (APYX): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/APYX"><img src="https://stoquant.com/badge/APYX.svg" alt="Apyx Medical Corporation (APYX) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.